{"id":48136,"date":"2022-09-08T20:02:06","date_gmt":"2022-09-08T18:02:06","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\/"},"modified":"2022-09-08T20:02:06","modified_gmt":"2022-09-08T18:02:06","slug":"feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\/","title":{"rendered":"Feinstein Institutes Researchers Spotlight Personalized Clinical Trials to Advance Scientific Research"},"content":{"rendered":"
\n

\nDr. Karina Davidson serves as guest editor in a special Harvard Data Science Review issue outlining the potential N-of-1 clinical trials hold for scientific research.<\/i>\n<\/p>\n

MANHASSET, N.Y.–(BUSINESS WIRE)–Clinical trials are the backbone of scientific progress; every new drug, device, or medical procedure must be investigated to ensure their safety and efficacy. Standard clinical trials \u2013 like randomized controlled trials (RCT) \u2013 often include large groups of people and are not tailored for personalized care. In a new, special issue of Harvard Data Science Review<\/a>,<\/i> researchers at The Feinstein Institutes for Medical Research<\/a> gathered data from around the world that explores personalized, also known as N-of-1, clinical trials and how they benefit the patient.\n<\/p>\n

<\/a>
<\/a><\/p>\n

\nThe collection of research, titled \u201cPersonalized (N-of-1) Trials: Methods, Applications, and Impact,\u201d was compiled under the direction of <\/i>Karina Davidson, PhD,<\/a> director of the Institute of Health System Science<\/a> at the Feinstein Institutes. In an introductory essay authored by Dr. Davidson, along with several other Feinstein Institutes researchers, they provide evidence and commentary about why personalized trials hold the key to deliver tailored, patient-centric treatment options, all while allowing investigators to collect meaningful and in-depth scientific data.\n<\/p>\n

\n\u201cThere is no one-size-fits-all approach to research and personalized clinical trials offer a unique way to conduct research while individualizing care,\u201d said Dr. Davidson, Donald and Barbara Zucker Endowed Professor in Health Outcomes. \u201cThrough this special collection of research, we hope to inform and educate both the general public and fellow investigators about what personalized trials can offer patients and scientists.\u201d\n<\/p>\n

\nPersonalized trials may not work for all types of research, but could be most beneficial for behavioral health and chronic conditions like asthma, weight or pain management studies. Personalized clinical trials can also shed insight on when to discontinue a medication or treatment \u2013 allowing a patient to determine what drugs are vitally needed and what are unnecessary.\n<\/p>\n

\nThe research collection in Harvard Data Science Review<\/i> discusses the current pitfalls investigators face in order to implement more personalized clinical trials \u2013 such as explaining what the term N-of-1 means to the general public. To identify those concerns, Dr. Davidson shares results from a focus group she and colleagues conducted around personalized trials, the terminology used and the attitudes both patients, clinicians and research leaders feel about them.\n<\/p>\n

\n\u201cPersonalized clinical trials can advance science while providing individualized treatment to those enrolled in the study,\u201d said Kevin J. Tracey, MD,<\/a> president and CEO of the Feinstein Institutes and Karches Family Distinguished Chair in Medical Research. \u201cDr. Davidson and colleagues shed light from valuable research across the globe on the challenges and solutions to implement N-of-1 trials.\u201d\n<\/p>\n

\nAbout the Feinstein Institutes
\n
<\/i><\/b>The Feinstein Institutes for Medical Research<\/a><\/i> is the home of <\/i>the<\/i> research <\/i>institutes<\/i> <\/i>of Northwell Health, the largest health care provider and private employer in New York State.<\/i> <\/i>Encompassing<\/i> <\/i>50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health system science, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine \u2013 a new field of science that has the potential to revolutionize medicine. For more information about how we produce knowledge to cure disease, visit<\/i> <\/i>http:\/\/feinstein.northwell.edu<\/a><\/i> <\/i>and follow us on<\/i> <\/i>LinkedIn<\/a><\/i>.<\/i>\n<\/p>\n

Contacts<\/b> <\/p>\n

\nJulianne Mosher Allen
\n
516-880-4824
\n
jmosherallen@northwell.edu<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

Dr. Karina Davidson serves as guest editor in a special Harvard Data Science Review issue outlining the potential N-of-1 clinical trials hold for scientific research. MANHASSET, N.Y.–(BUSINESS WIRE)–Clinical trials are the backbone of scientific progress; every new drug, device, or medical procedure must be investigated to ensure their safety and efficacy. Standard clinical trials \u2013 … [Read more…]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48136","6":"format-standard","7":"category-industry"},"yoast_head":"\nFeinstein Institutes Researchers Spotlight Personalized Clinical Trials to Advance Scientific Research - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Feinstein Institutes Researchers Spotlight Personalized Clinical Trials to Advance Scientific Research - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Dr. Karina Davidson serves as guest editor in a special Harvard Data Science Review issue outlining the potential N-of-1 clinical trials hold for scientific research. MANHASSET, N.Y.–(BUSINESS WIRE)–Clinical trials are the backbone of scientific progress; every new drug, device, or medical procedure must be investigated to ensure their safety and efficacy. Standard clinical trials \u2013 ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-08T18:02:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220908005994\/en\/1566160\/21\/Davidson_2022.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Feinstein Institutes Researchers Spotlight Personalized Clinical Trials to Advance Scientific Research\",\"datePublished\":\"2022-09-08T18:02:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\\\/\"},\"wordCount\":575,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005994\\\/en\\\/1566160\\\/21\\\/Davidson_2022.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\\\/\",\"name\":\"Feinstein Institutes Researchers Spotlight Personalized Clinical Trials to Advance Scientific Research - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005994\\\/en\\\/1566160\\\/21\\\/Davidson_2022.jpg\",\"datePublished\":\"2022-09-08T18:02:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005994\\\/en\\\/1566160\\\/21\\\/Davidson_2022.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220908005994\\\/en\\\/1566160\\\/21\\\/Davidson_2022.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Feinstein Institutes Researchers Spotlight Personalized Clinical Trials to Advance Scientific Research\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Feinstein Institutes Researchers Spotlight Personalized Clinical Trials to Advance Scientific Research - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\/","og_locale":"en_US","og_type":"article","og_title":"Feinstein Institutes Researchers Spotlight Personalized Clinical Trials to Advance Scientific Research - Pharma Trend","og_description":"Dr. Karina Davidson serves as guest editor in a special Harvard Data Science Review issue outlining the potential N-of-1 clinical trials hold for scientific research. MANHASSET, N.Y.–(BUSINESS WIRE)–Clinical trials are the backbone of scientific progress; every new drug, device, or medical procedure must be investigated to ensure their safety and efficacy. Standard clinical trials \u2013 ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-08T18:02:06+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220908005994\/en\/1566160\/21\/Davidson_2022.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Feinstein Institutes Researchers Spotlight Personalized Clinical Trials to Advance Scientific Research","datePublished":"2022-09-08T18:02:06+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\/"},"wordCount":575,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220908005994\/en\/1566160\/21\/Davidson_2022.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\/","url":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\/","name":"Feinstein Institutes Researchers Spotlight Personalized Clinical Trials to Advance Scientific Research - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220908005994\/en\/1566160\/21\/Davidson_2022.jpg","datePublished":"2022-09-08T18:02:06+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220908005994\/en\/1566160\/21\/Davidson_2022.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220908005994\/en\/1566160\/21\/Davidson_2022.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/feinstein-institutes-researchers-spotlight-personalized-clinical-trials-to-advance-scientific-research\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Feinstein Institutes Researchers Spotlight Personalized Clinical Trials to Advance Scientific Research"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48136","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48136"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48136\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48136"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48136"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48136"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}